Cidara Therapeutics(us:CDTX)
23.22
+3.15%
Updated on 2024-12-22
Open:22.12
Close:23.22
High:24.00
Low:21.20
Pre Close:22.51
Volume:148362.00
Amount:3.35M
Turnover:1.59%
Shares:9.36M
MarketCap:217.24M
About Cidara Therapeutics Company
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Company Name: Cidara Therapeutics
Company Address: 6310 Nancy Ridge Drive,Suite 101
Employees: 69
Fiscar Year: 12-31
IPO Date: 2015-04-15
Website: http://www.cidara.com
CIK: 1610618
View all SEC Filings
About
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.
Address:6310 Nancy Ridge Drive,Suite 101
Website:http://www.cidara.com
Market Movers